Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ELVN
ELVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ELVN News
Surge in Options Trading Volume for Apple and Coinbase
1d ago
NASDAQ.COM
Avidity Partners Increases Stake in Enliven Therapeutics
May 13 2026
Fool
Enliven's ELVN-001 Shows Promising Trial Results and Analyst Support
May 12 2026
stocktwits
Enliven Therapeutics Reports Positive Data on ELVN-001 for CML
May 12 2026
PRnewswire
Enliven Therapeutics Announces Updated Clinical Data for ELVN-001
May 12 2026
Newsfilter
Helen Collins Sells 40,000 Shares of Enliven Therapeutics
Mar 28 2026
NASDAQ.COM
Enliven's CMO Exercises and Sells Stock Options for $1.2 Million
Mar 28 2026
Fool
Enliven's CMO Sells 40,000 Shares for $1.2 Million
Mar 28 2026
Yahoo Finance
Terns Acquisition Sparks Hope for Enliven Therapeutics' Blood Cancer Pipeline
Mar 25 2026
stocktwits
ENLIVEN THERAPEUTICS INC: MIZUHO INCREASES TARGET PRICE FROM $41 TO $45
Mar 25 2026
moomoo
Enliven Therapeutics (ELVN.US) Officer Plans to Sell $3.08 Million in Common Stock via Form 144
Mar 24 2026
moomoo
Enliven Therapeutics Q4 Earnings Miss Expectations
Mar 03 2026
seekingalpha
Enliven Therapeutics Executive Sells 20,000 Shares
Feb 01 2026
Fool
Enliven Therapeutics COO Anish Patel Sells 48,300 Shares for $1,351,000
Jan 13 2026
Yahoo Finance
Oncolytics Biotech Advances Immunotherapy for Accelerated Approval in Oncology
Jan 12 2026
Newsfilter
CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026
Jan 09 2026
Benzinga
Show More News
